Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.48
+0.38002.36%
Post-market: 16.480.00000.00%17:03 EDT
Volume:15.66M
Turnover:257.45M
Market Cap:18.88B
PE:-11.37
High:16.71
Open:16.22
Low:16.05
Close:16.10
Loading ...

Pre-Bell|U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine

Tiger Newspress
·
17 Dec 2024

Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial

Dow Jones
·
17 Dec 2024

Teva, Sanofi Say Drug to Treat IBD Met Primary Targets

Reuters
·
17 Dec 2024

U.S.-Listing of Teva Pharmaceuticals up 21% Premarket After Co's Bowel Disease Drug With Sanofi Meets Main Goals in Mid-Stage Trial

THOMSON REUTERS
·
17 Dec 2024

Teva announces new patient access program with Direct Relief

TIPRANKS
·
11 Dec 2024

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

GlobeNewswire
·
11 Dec 2024

Teva Pharmaceutical's AJOVY® is Proven to be Effective in Children with Migraine

GuruFocus
·
06 Dec 2024

Teva Pharmaceutical to Divest Japanese Venture to JKI

MT Newswires Live
·
06 Dec 2024

Teva to divest Teva-Takeda business venture in Japan

TIPRANKS
·
06 Dec 2024

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

GlobeNewswire
·
06 Dec 2024

Teva presents data from SPACE study

TIPRANKS
·
04 Dec 2024

Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients

MT Newswires Live
·
04 Dec 2024

TEVA Stock Down 10% in a Month: Should You Buy the Dip?

Zacks
·
29 Nov 2024

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire
·
26 Nov 2024

Emerging-Markets Stocks Have Rarely Been So Hated. It's Time To Buy -- WSJ

Dow Jones
·
23 Nov 2024

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25

Insider Monkey
·
21 Nov 2024